Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin

BACKGROUND: Oral anticoagulation such as warfarin and dabigatran is indicated for atrial fibrillation (AF) patients at risk of ischemic stroke. Dabigatran etexilate was developed to address the limitations of warfarin, including the need for regular blood monitoring, which has the potential to lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Eileen, Sander, Stephen D., Hess, Gregory P., Ghosh, Sabyasachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397811/
https://www.ncbi.nlm.nih.gov/pubmed/26521116
http://dx.doi.org/10.18553/jmcp.2015.21.11.1039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397811/
https://www.ncbi.nlm.nih.gov/pubmed/26521116
http://dx.doi.org/10.18553/jmcp.2015.21.11.1039

Ejemplares similares